Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
19.69
+0.08 (0.41%)
At close: Dec 11, 2025, 4:00 PM EST
19.36
-0.33 (-1.68%)
After-hours: Dec 11, 2025, 7:45 PM EST
Evommune Market Cap
Evommune has a market cap or net worth of $592.23 million as of December 11, 2025.
Market Cap
592.23M
Enterprise Value
516.33M
1-Year Change
n/a
Ranking
Category
Stock Price
19.69
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $592.23M, an increase of 23.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 592.23M | 0.41% |
| Dec 10, 2025 | 589.82M | 9.92% |
| Dec 9, 2025 | 536.58M | -3.25% |
| Dec 8, 2025 | 554.63M | -15.80% |
| Dec 5, 2025 | 658.70M | -0.14% |
| Dec 4, 2025 | 659.60M | 3.35% |
| Dec 3, 2025 | 638.25M | 0.81% |
| Dec 2, 2025 | 633.13M | 0.67% |
| Dec 1, 2025 | 628.92M | 0.97% |
| Nov 28, 2025 | 622.91M | 6.70% |
| Nov 26, 2025 | 583.81M | 3.52% |
| Nov 25, 2025 | 563.95M | -3.25% |
| Nov 24, 2025 | 582.90M | 3.58% |
| Nov 21, 2025 | 562.75M | - |
| Nov 20, 2025 | 562.75M | -3.01% |
| Nov 19, 2025 | 580.20M | -4.46% |
| Nov 18, 2025 | 607.27M | 3.80% |
| Nov 17, 2025 | 585.01M | 6.28% |
| Nov 14, 2025 | 550.42M | 0.44% |
| Nov 13, 2025 | 548.01M | -6.66% |
| Nov 12, 2025 | 587.11M | 0.26% |
| Nov 11, 2025 | 585.61M | 0.78% |
| Nov 10, 2025 | 581.10M | 4.94% |
| Nov 7, 2025 | 553.73M | 15.06% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |